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ABSTRACT
Objective To determine the prognostic value of myocardial ischemia, function and 
coronary risk factors on total and hard cardiac events using myocardial perfusion 
imaging in a Japanese population.
Methods A prospective cohort study was performed in 117 Japanese hospitals, each 
with a nuclear cardiology facility. A total of 4,031 patients with suspected or 
confirmed ischemic heart disease were registered. The patients were followed up for 
a year to investigate total and hard events, and those who had any events were 
followed up for 3 years to evaluate subsequent hard events. A stress-rest gated 
myocardial perfusion study was performed with 99mTc-tetrofosmin using gated single-
photon-emission computed tomography (SPECT) and analyzed by semi-quantitative 
scores. 
Results During the one-year follow-up period, 263 (6.5%) patients had total events 
comprising all-cause death, non-fatal myocardial infarction (MI), heart failure, 
unstable angina, angina pectoris and coronary revascularization. Cardiac death 
occurred in 23 patients (0.6%) and non-fatal MI in 11 (0.3%). Among patients with 
ejection fraction (EF) of <45% and a summed difference score (SDS) of ≥2, 18.7% 
(2.4% for cardiac death and 0.6% for non-fatal MI) experienced total events 
compared with 3.9% (0.3% for cardiac death and 0.2% for non-fatal MI; p <0.0001) 
of those with EF ≥45% and SDS <2.  Multivariate analysis identified EF, SDS, age, 
history of revascularization and diabetes as significant predictors of all events, while 
the significant predictors were age and EF for hard events. When the patients who 
had heart failure in the first year were followed up, 9 of 41 (22.0%) experienced 
cardiac death in the subsequent three-year follow-up period.
Conclusion Myocardial ischemia defined by SDS and ventricular function were the 
main predictors of total events despite the relatively low incidence of hard events in 
this Japanese population. In patients with cardiac events in a year, closer attention 
should be paid to subsequent hard events particularly in patients with heart failure.
Key Words: Myocardial perfusion imaging, gated SPECT, prognosis, multi-center 
study, cardiac events
INTRODUCTION
   Nuclear cardiology tests have been applied to patients with suspected and 
proven coronary artery diseases for optimal diagnosis and prognostic evaluation. Risk 
stratification in patients with a clinical risk of a subsequent cardiac event has been 
considered an important objective of nuclear cardiology. [1] The possibility of a 
different role of nuclear cardiology for risk evaluation among the Japanese population 
has been discussed because such a population has a relatively low disease prevalence 
and mortality, milder ischemic events, and different aspects of underlying risks for 
coronary artery diseases.[2-4] 
 We therefore performed a multi-center cohort study to establish a database 
called the Japanese Assessment of Cardiac Events and Survival Study by quantitative 
gated single-photon emission computed tomography (SPECT) (J-ACCESS) 
involving 117 hospitals and 4,629 patients who were consecutively registered for 
follow-up.[5, 6] Therefore, the study reflected average nuclear cardiology practice in 
Japan. According to the initial summary of hard cardiac events during the 3-year 
follow-up period (n=4,031), hard events occurred in 2.4% of the patients; namely, 
cardiac death (1.4%) and non-fatal myocardial infarction (MI) (1.0%). The 
annualized cardiac event rate after normal myocardial perfusion SPECT was 0.5% for 
hard events and 0.8% if severe heart failure requiring hospitalization was included. 
Although left ventricular (LV) volumes and ejection fraction (EF) were important 
factors for predicting cardiac events in addition to semi-quantitative summed stress 
score, stress-induced ischemia (summed difference score) was not the primary 
predictor of hard events. 
 In the present study, we postulated that induced ischemia detected by myocardial 
perfusion SPECT was related to the rate of total events, including unstable angina, 
heart failure, coronary intervention and bypass grafting. The present study analyzes 
the Japanese large-scale SPECT database with specific focus on the relationship of 
total and hard events over a one-year period to determine the role of nuclear 
cardiology in a Japanese population. Subsequent hard events by the third year 
following the initial cardiac events were also investigated.
PATIENTS AND METHODS
Subjects
The principal design of the J-ACCESS study is described elsewhere.[5] 
The registration period was between October 1, 2001 and March 31, 2002. The 
patients underwent stress and rest myocardial perfusion SPECT using 
electrocardiographically gated 99mTc-tetrofosmin SPECT. The inclusion criteria 
included patients ≥ 20 years of age who were undergoing stress-rest gated SPECT 
due to suspected or known ischemic heart diseases.  A total of 4,629 consecutive 
patients were registered at 117 hospitals. Since 223 patients (4.8%) were lost to 
follow-up, the prognostic data were derived from a follow-up of 4,406 of the 
patients (95.2%). Early revascularization within 60 days of the SPECT study was 
excluded from the analysis, [7] and 4,031 patients were analyzed for first-year 
events in the present study. Patients with onset of MI or unstable angina pectoris 
within 3 months, valvular heart disease, idiopathic cardiomyopathy, severe 
arrhythmia, heart failure with class III or higher New York Heart Association 
(NYHA) classification, and severe hepatic or renal disorders were excluded. 
Myocardial perfusion imaging
Most of the hospitals (99%) used a one-day protocol for stress and rest 
SPECT studies. The standard dose of 99mTc-tetrofosmin was administered, with 
mean doses of 305 and 709 MBq for the first and second studies, respectively. 
Only a few hospitals (1%) used a 2-day protocol. Either an exercise (69%) or 
pharmacological stress (31%) protocol was used, with dipyridamole or adenosine 
triphosphate used in the latter . All institutions used multi-detector SPECT 
systems. Patients were examined by gated SPECT at least under a resting 
condition. The SPECT image acquisition conditions are described elsewhere in 
detail.[8]
Quantitative and visual analysis of SPECT data
Quantitative gated SPECT data were analyzed at all hospitals using QGS 
software (Cedars Sinai Medical Center, CA, USA) and standard automated 
processing methods with manual modification if necessary. The parameters of EF 
(%), end-diastolic volume (EDV, mL) and end-systolic volume (ESV, mL) were 
calculated at each institute. Visual scoring used the validated 20-segment model, 
and defects were scored from 0 to 4 in individual segments as 0, normal; 1, mildly 
reduced; 2, moderately reduced; 3, severely reduced and 4, absent.[9] The summed 
stress score (SSS) and the summed rest score (SRS) were calculated.  The summed 
difference score (SDS) was defined as the difference between the SSS and the 
SRS, and was indicated as the amount of stress-induced ischemia. The severity of 
myocardial perfusion defects for the prognostic model was categorized into normal 
(0 - 3), mild (4 - 8), moderate (9 -13) and severely (> 13) abnormal SSS. 
Reproducibility of quantification
The precision of the QGS parameters or preference-based variability 
among institutions was excellent, with the standard deviation of EF being < 3.6% 
and the coefficient of variation of EDV being < 9.3%.[10] All images were scored 
at the 117 participating hospitals. It was necessary to provide support to hospital 
staff in interpretation and quantification of typical SPECT images. We also 
compared the segmental scores between participating hospitals and the Image 
Evaluation Committee using a sample group of 81 studies. The agreement of 
summed scores was good (kappa, 0.85).
Patient follow-up and definition of cardiac events
Physicians at each hospital investigated the types of cardiac events 1 year 
after registration based on medical records. We used one-year analysis in this study, 
because we considered the practical importance of predicting every type of event at 
an early year. Indeterminate medical records were confirmed by written 
questionnaires and by direct telephone interview. Hard cardiac events were defined as 
cardiac death and non-fatal MI. Total events were defined in addition to hard events 
as death from non-cardiac causes, unstable angina, newly diagnosed angina pectoris, 
heart failure, coronary intervention and coronary bypass grafting. The description of 
angina symptom preceded to PCI and CABG was classified into the events of PCI 
and CABG, respectively. The end point of follow-up was any of the initial events 
listed above. Patients with at least one event within the previous year were followed 
up to identify subsequent hard events in the second and third year. The number of 
hard events included in the above total events was analyzed for comparison.
Ethics approval
The institutional review board at each of the involved hospitals approved the 
J-ACCESS protocols, and written informed consent was obtained from all patients 
who participated in the study.
Statistical analysis 
  Continuous variables are expressed as mean ± standard deviation 
(SD). We applied the Wilcoxon rank sum test to compare results from patients with 
and without cardiac events, and the χ2 test to categorical data. The independent 
variables in the univariate Cox proportional hazard model included age, gender, 
cardiac risk factors (chest pain, body mass index, hypertension, dyslipidemia, 
diabetes mellitus, smoking history, family history of coronary artery disease, prior 
MI and revascularization), summed scores, QGS parameters of EF and volumes. 
The multivariate Cox proportional hazard model was applied using a forward 
stepwise method. Statistical significance was defined as P < 0.05. 
RESULTS
Patient characteristics
Table 1 shows the demographics of the patients. The average age was 65.9 
±10.1 years. A history of MI and diabetes each was identified in ~30% of the patients, 
and dyslipidemia was evident in ~50% of them. The EF determined by QGS was 
62%±14%, and EDV was 85±36 mL. 
Cardiac events
 A total of 263 patients (6.5%) experienced cardiac events within one year, of 
which 23 (0.6%) were cardiac death and 11 (0.3 %) were non-fatal MI. Figure 1 
shows that the incidences of diabetes, a history of myocardial infarction and 
hypertension were higher in the event group. The frequency of dyslipidemia and 
smoking did not significantly differ between the groups. 
 The initial events and subsequent events during the first year are listed in 
Table 2. The diagnosis of angina pectoris�without additional cardiac events in the first 
year (n=22) was confirmed by coronary angiography (n=16) and history of coronary 
revascularization (n=4). In the remaining two patients, the diagnosis of angina 
pectoris was clinically made 192 days and 316 days after the registration, and the 
patients were medically treated without coronary angiography. The initial events were 
angina pectoris (n=23), PCI or CABG (n=135), heart failure (n=41), non-fatal MI 
(n=10) and all-cause death (n=54). When subsequent hard events were observed, one 
had non-fatal MI and six had cardiac death within a year. Figure 2 summarizes what 
types of hard events followed after the events of the first year. When the patients 
were followed up by the third year, 5 patients had cardiac death and 5 patients had 
non-fatal MI in the second and third years. Following the medically treated angina 
(n=23), 2 patients (8.7%) had non-fatal MI. Patients with PCI as the first event had 
repeated revascularization in a year in 11 of 114 patients (9.6%), and 5 (4.4%) had 
hard events by the third year, whereas after CABG (n=21), no patients had hard 
events during the follow-up period. Conversely, in 41 patients with non-severe (n=4) 
and severe heart failure (n=37), cardiac death occurred in 9 patients (22.0%). Average 
EF, EDV, SSS, SDS of the heart failure patients without cardiac death (n=32) were 
42±16% and 136±65ml, 21±16 and 2±4, respectively; whereas those with cardiac 
death (n=9) were 40±15% and 150±93 ml, 14±16 and 2±4, respectively (p=n. s. for 
all). Significant coronary stenosis or subsequent revascularization were observed in 2 
of 9 patients with cardiac death (22.2%) and 14 of  32 patients without cardiac death 
(43.4%) (p=n. s.).
Patients with total events were older and comprised a higher ratio of males 
than those without total events (Table 3). During the follow-up, patients with cardiac 
events had higher SSS (p <0 .0001) and SDS (p < 0.0001) than those without events. 
The EF was lower (p < 0.0001) and ESV was higher (p < 0.0001) in the group with 
cardiac events in comparison to that without cardiac events. 
 Table 4 summarizes the effects of EF, ESV, SSS and SDS on cardiac events. 
Event rates were 3-fold higher among patients with EF < 45% than those with EF > 
45% (15.6% vs. 5.5%, p < 0.0001). The ratio of hard event rates included in total 
events was 0.6% and 2.6% in patients with EF > 45% and < 45%, respectively. The 
incidence of total event rates was also higher among male and female patients with 
ESV ≥60 mL and ≥40 mL, respectively (p < 0.0001), using cutoff values for 
Japanese.[8] Patients with higher SSS and SDS had higher total event rates (p < 
0.0001), in which SDS was significant for total events. The total event rates 
proportionally increased according to the increase in SSS categories (p < 0.0001) 
(Figure 3). The occurrence of hard events was <0.6% for patients with SSS < 8, and 
>1.5% for SSS > 9 (p = 0.0027).
 When cardiac event rates were analyzed with a threshold of SSS = 9 (a 
threshold value between slight and moderate severity) and with the presence of 
diabetes, the event rate was highest (12.5%) for diabetic patients with SSS ≥ 9, but 
decreased for non-diabetic patients with SSS ≥ 9 (9.0%), diabetic patients with SSS < 
9 (6.4%) and non-diabetic patients with SSS < 9 (4.1%) (p < 0.0001, Figure 4A). The 
hard event rates were lower but were decreased in this order (p<0.0001). When 
analyzed with the threshold of SDS = 2 and EF = 45%, total event rates of patients 
with SDS>2 and EF <45% were 4.8-fold higher than those with SDS<2 and EF>45% 
(p<0.0001). In patients with EF ≥ 45%, event rates were higher among those with 
SDS ≥ 2 than those with SDS < 2 (p = 0.0001, Figure 4B). The χ2 test for trend was 
significant for both total (p<0.0001) and hard (p=0.0003) event rates.
Univariate and multivariate Cox regression analyses
 Risk factors and SPECT parameters analyzed for predicting cardiac events 
with a univariate Cox regression model revealed that significant variables included a 
history of MI (Hazard ratio, 1.706, p < 0.0001), diabetes (1.586, p = 0.0003), 
hypertension (1.308, p = 0.0337), age (1.028, p < 0.0001) and body mass index 
(BMI)  (0.956, p = 0.0219). All values of SSS, SRS, SDS, EF, EDV and ESV were 
significant and included hazard ratios of 1.030, 1.024, 1.078, 0.965, 1.008 and 1.010, 
respectively (p < 0.0001 for all). Table 5 summarizes the principal independent 
variables that were finally accepted by a multivariate model. Variables of EF, SDS, 
age, history of revascularization and diabetes were significant predictors in the order 
of ?2 values for total events. On the other hand, age and EF were significant 
predictors for hard events.
Incremental values of clinical factors and ischemia
 Global ?2 values were calculated by a Cox proportional hazard model 
using combinations of age, diabetes, history of revascularization, SDS and ESV 
(Figure 5). The global ?2 values by adding parameters in this order were 15.5, 
26.8, 51.8, 93.5 and 148.0, respectively. Adding SDS to the combination of age, 
diabetes and history of revascularization yielded 1.8-fold?2 values in the 
prediction of total events.
DISCUSSION
 The J-ACCESS investigation is the first large-scale prognostic study using 
myocardial perfusion SPECT data from an Asian population. We previously 
summarized prognostic values of myocardial perfusion gated SPECT for predicting 
hard events and found that the frequency of hard events was significantly lower in a 
Japanese population than in populations focused on in US studies.[6] When total 
events were analyzed in the present study, stress-induced ischemia was a significant 
predictor of future events. The main conclusion of this study was that the hard event 
rate was significantly affected by baseline LV function, whereas total events were 
determined by both induced ischemia and ventricular function. Diabetes was one of 
the most important predictors for cardiac events in Japan, for both total and hard 
events. The importance of intensive care following the first year’s events should be 
emphasized.
 The evidence level of nuclear studies in the Japanese population has 
remained limited, and significant predictors of cardiac events differ among studies. 
One Japanese study examined cardiac events in elderly patients using quantitative 
gated SPECT.[11] Of 18 total cardiac events among 175 registered patients, only 2 
cardiac deaths and 1 non-fatal MI occurred during 3.4 years of follow-up. Another 
investigation of mid-term follow-up (average period of 26.9 months) in a hospital 
included a 201Tl/99mTc dual nuclide study of 1988 patients.[12] The annual event rates 
of cardiac death were 0.1% and 2.9% for SSS 0 - 3 and > 13, respectively, and non-
fatal MI and unstable angina occurred in 0.9% and 2.4% for SSS 0 - 3 and > 13, 
respectively. Although these studies suggested a relatively low incidence of hard 
events, statistical analysis necessitated far more patients considering the low 
incidence of cardiac death. The first J-ACCESS report thus confirmed the low 
incidence of hard events from the Japanese multi-center study, and this study 
demonstrated an additional role of stress-induced ischemia for total events.
The prognostic value of combined myocardial perfusion and ventricular 
function has been studied. The LV EF provides incremental prognostic information 
over perfusion in predicting cardiac death, whereas stress-induced ischemia predicts 
acute coronary syndromes.[7, 13-15] A European study by Petix et al. found that the 
most powerful predictor of all cardiac events was the degree of myocardial ischemia, 
while adding ventricular function data yielded an incremental value for predicting 
hard events but not all events.[14] Although the settings differed among these studies, 
our data suggested a closer relationship between hard events and baseline LV 
function and between all events and both stress-induced ischemia and LV function in 
our population. Shaw et al. studied the role of resting and stress myocardial perfusion 
imaging, and found that rest imaging might be reflective of a patient's baseline risk, 
whereas stress ischemia is defined as a risk inherent in the presenting symptom 
burden.[16] The baseline LV function may be related to EF, ventricular volume and 
myocardial perfusion defect in the resting condition. The present study demonstrated 
that the combination of perfusion and ventricular function determined by gated 
SPECT helped to predict cardiac events, which is consistent with a recent Japanese 
prognostic study in acute coronary syndrome. [17] 
Since SDS yielded significant prognostic power for predicting total events 
by global?2 analysis, the incremental value of myocardial ischemia over clinical 
background factors and ventricular function was demonstrated.  The insignificant 
effect of SDS on hard events in the initial J-ACCESS summary was not anticipated, 
but it might be explained partly by the consecutive patient registry in multiple 
centers. Although the registration was performed in patients suspected of having 
ischemic heart disease, the relatively low-risk profile of Japanese patients for 
coronary artery disease and selection biases between Japan and Western countries 
might also be related.
 The total-event analysis showed that diabetes and history of revascularization 
were important predictors. Additional predictors of gender, hypertension and prior MI 
were identified by univariate analysis. Hayes et al. reported similar univariate 
predictors from total events, including age, gender, hypertension, diabetes, history of 
MI and revascularization, adenosine stress and SSS.[18] Elhendy et al. examined 
predictors of cardiac events after revascularization using 99mTc tetrofosmin.[19] They 
found by using the multivariate Cox model that male gender, diabetes, stress rate-
pressure product and an abnormal scan were predictors of hard events, whereas male 
gender, diabetes and reversible defects were selected for all events. Shaw et al. 
emphasized the importance of metabolic syndrome and diabetes with multiple risk 
factors for enhancing cardiovascular risks, in which the prognosis of patients with 
five risk factors was particularly poor.[20] Finally, we emphasized that diabetes is 
one of the most important predictors in all Western and Japanese studies.[3, 9, 18-21]
 The J-ACCESS investigation can be fed back to clinical practice in a Japanese 
population. The factor of myocardial ischemia would become an important predictor 
for total events. Moreover, ~10% of patients with PCI as the first event repeated 
revascularization in a year, and 4.4% had hard events by the third year.  The event 
rate reflected the recent prognostic course in Japanese clinical practice and was 
comparable to that of the J-SAP (Japanese stable angina pectoris) study conducted 
since 2001.[22] In the J-SAP 1-1 report, additional PCI and/or CABG was required in 
33.2% of the group of PCI-preceding therapy in the average follow-up period of 3.4 
years, and overall rate of cardiac death and acute coronary syndrome was 4.7% in the 
same period.  Intensive care would be required following the first soft events. On the 
other hand, since an episode of heart failure in the first year was highly associated 
with subsequent cardiac death (22%), strategies to maintain or improve cardiac 
function should be sought to reduce cardiac death. Cardiac death following the first 
episode of heart failure could not be predicted by the initial ventricular function. The 
ischemia-related scores of SSS and SDS could not predict cardiac death either, 
probably because their cardiac deaths might be related to subsequent deterioration of 
cardiac function in addition to ischemic events. Considering the low incidence of 
obesity, the insignificant impact of dyslipidemia and high impact of diabetes in a 
Japanese population, intensive care for diabetic patients might be of prime 
importance for reducing cardiac events. However, since lifestyle changes in Japan in 
recent decades have increased the prevalence of hypercholesterolemia and diabetes, 
attention should be paid to future trends for coronary risk factors in Japan.[4] 
 One of the limitations of this study is related to the participation of 117 
institutions.  When only a few institutions are involved in a large-scale study, 
diagnostic methods, therapeutic strategies and follow-up can be controlled quite 
uniformly. Conversely, when >100 hospitals are involved, as was the case in the J-
ACCESS study, the diagnostic and therapeutic approaches including indications for 
interventions cannot be made strictly consistent. The indication bias towards 
revascularization also is related to different approaches to patients with slight 
ischemia between Japan and Western countries. Second, each institution performed 
quantitative evaluations. To overcome inter-institutional differences, we repeatedly 
provided support to the participants in scoring at several workshops, and variations in 
QGS results were also examined to minimize the effect of preference-based 
differences.[10] 
CONCLUSION
 The J-ACCESS study demonstrated a relatively low incidence of hard events 
among Japanese, compared with American and European populations. When total 
and hard events were analyzed, myocardial stress-induced ischemia and ventricular 
function were the main predictors of total cardiac events, while baseline LV function 
affected the incidence of hard events. Diabetes was the most important predictor of 
cardiac events among coronary risk factors in this Japanese population, indicating a 
need for targeted efforts for its management . Careful treatment strategy should be 
considered after an episode of heart failure, because subsequent risk of hard events is 
high. 
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FIGURES
Figure 1
Incidence of associated clinical factors in 
patients with and without total events (black 
and white bars, respectively). MI, myocardial 
infarction; CAD, coronary artery disease
Figure 2 
The first event in a year and subsequent hard events in the second and third years. 
Number of patients is shown in parentheses.
Figure 3 
Event rates per year for SSS 
categories with no (0-3) mild (4 
- 8), moderate (9 - 13) and 
severe (≥14) scores. ?2 values 
for trends are 136.0 (p < 0.0001) 
and 9.022 (p=0.0027) for the 
total and hard events, 
respectively. P values among 4 
groups were based on?2 test.
Figure 4 
Total and hard events of cardiac 
death and non-fatal MI. Upper 
and lower panels indicate effects 
of diabetes and SSS, and of SDS 
and EF on total and hard events. 
Regarding diabetes and SSS, 
the?2 value for the trend is 
143.8 (p < 0.0001) and 17.1 (p < 
0.0001) for total and hard events, 
respectively. Regarding EF and 
SDS, it is 162.1 (p < 0.0001) and 
15.2 (p = 0.0003) for total and 
hard events, respectively. P 
values among 4 groups were 
based on?2 test.
Figure 5 
Incremental prognostic value of clinical and perfusion variables for predicting total 
cardiac events. Revasc., revascularization; DM, diabetes mellitus.
Table 1. Patient characteristics
Characteristic Mean±SD or %
Number of patients 4031
Background factors
 Age (years) 65.9±10.1
 Male sex 64%
 Typical chest pain 46%
 BMI (kg/m2)  23.7±3.2
 Diabetes mellitus 29%
 History of MI 29%
 H i s t o r y o f 
revascularization 36%
 Hypertension 55%
 Ischemia on ECG 51%
 Dyslipidemia 47%
 Current Smoker 16%
 Family history of CAD 12%
Perfusion score and left ventricular function
 SSS 8.7±11.2
 SRS 7.3±10.6
 SDS 1.4 ±3.8
 EF (%) 61.9±13.6
 EDV (mL) 84.7±36.0
?  ESV (mL) 35.8±29.0
Abbreviations 
BMI, body mass index; MI, myocardial infarction; ECG, electrocardiogram; CAD, 
coronary artery disease; SSS, summed stress score; SRS, summed rest score; SDS, 
summed difference score; EF, ejection fraction; EDV, end-diastolic volume; ESV, 
end-systolic volume
Table 2. Initial event and subsequent events during the first year
Initial event Subsequent events Subtotal Total
Angina pectoris (medically treated) 23
no additional events 22
non-fatal MI, severe HF, PCI, 
CABG 1
PCI 114






no additional events 20
PCI 1
HF 4
no additional events 3
cardiac death 1
severe HF










severe HF, cardiac death 1
severe HF, PCI 1
Death
cardiac death 15 54
? non-cardiac death 39?
263
MI, myocardial infarction; HF, heart failure; PCI, percutaneous coronary 
intervention; CABG, coronary artery bypass grafting; severe HF denotes HF 
requiring hospitalization for treatment.
Table 3. Background factors and SPECT results in patients with and without events
Parameters Total events No events p value
Number 263 (6.5%) 3768 (94.5%)
Age (y) 68.3 ±9.6 65.7±10.1 <0.0001
Male sex (n, 
%) 188 (71%) 2392 (63%) 0.0109
BMI (kg/m2) 23.3±3.2 23.7±3.2 0.0299
SSS 13.6±13.1 8.3±11.0 <0.0001
SRS 10.7±12.2 7.0±10.5 <0.0001
SDS 2.9±5.0 1.3±3.7 <0.0001
EF (%) 54.9±14.9 62.4±13.3 <0.0001
EDV (mL) 99.0±45.4 83.7±35.0 <0.0001
ESV (mL) 49.5±38.9 34.9±27.9 <0.0001
Abbreviations in Table 1
Table 4. Total events and hard events in a year
? ? Total event rate No. of hard events ?






































































































Abbreviations in Table 1
Table 5. Significant variables for cardiac events by Cox multivariate analysis
Variables
Hazard 
ratio 95% CI Wald?2 p
Total events
EF 0.969 0.961-0.977 71.0 <0.0001
SDS 1.071 1.047-1.096 34.7 <0.0001
Age 1.031 1.017-1.045 19.9 <0.0001
History of 
revascularization 1.582 1.236-2.024 14.0 0.0002
Diabetes mellitus 1.315 1.021-1.693 4.5 0.0331
Hard events
Age 1.063 1.020-1.108 8.26  0.0041
EF 0.951 0.915-0.989 6.32 0.0119
Diabetes mellitus 1.836 0.913-3.694 2.90
n.s. 
(0.0885)
Abbreviations in Table 1
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